UK markets closed

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
40.90-0.32 (-0.78%)
At close: 04:00PM EDT
40.00 -0.90 (-2.20%)
After hours: 04:05PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts16161717
Avg. Estimate-1.72-1.57-6.59-5.14
Low estimate-2.13-1.84-7.51-6.83
High estimate-1.32-1.22-4.71-2.23
Year ago EPS-2.25-2.23-8.25-6.59
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts15151617
Avg. Estimate122.77M132.99M511.6M634.5M
Low estimate108.5M121.9M501.5M559M
High estimate129.7M139.9M527.7M739M
Year ago sales108.31M98.05M434.25M511.6M
Sales growth (year/est)13.40%35.60%17.80%24.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-2.07-2.08-1.62-1.73
Actual EPS-2.25-2.23-1.52-2.03
Difference-0.18-0.150.1-0.3
Surprise %-8.70%-7.20%6.20%-17.30%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.72-1.57-6.59-5.14
7 days ago-1.65-1.59-6.39-5.06
30 days ago-1.63-1.58-6.44-4.96
60 days ago-1.63-1.58-6.45-4.9
90 days ago-1.6-1.5-6.28-4.35
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days3628
Up last 30 days58311
Down last 7 daysN/AN/AN/AN/A
Down last 30 days96105
Growth estimatesRAREIndustrySector(s)S&P 500
Current qtr.23.60%N/AN/AN/A
Next qtr.29.60%N/AN/AN/A
Current year20.10%N/AN/AN/A
Next year22.00%N/AN/AN/A
Next 5 years (per annum)8.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A